Pacer Advisors, Inc. Albireo Pharma, Inc. Transaction History

Pacer Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$28.9 - $36.87 $33,263 - $42,437	-1,151 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$32.03 - $42.85 $2,626 - $3,513	82 Added 7.67%	1,151 $41,000
Q4 2020 Jan 20, 2021	BUY	$31.56 - $42.16 $33,737 - $45,069	1,069 New	1,069 $40,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.